Stock market today: Which are top gainers and losers on NSE & BSE on July 1? Check list

Stock Market Gains July 1 2026: Stock market today: Which are top gainers and losers on NSE & BSE on July 1? Check list

Benchmark equity indices rebounded on Wednesday after two consecutive sessions of losses Benchmark equity indices rebounded on Wednesday after two consecutive sessions of losses, supported by positive global market trends and a decline in crude oil prices.The BSE Sensex climbed 443.97 points, or 0.58 per cent, to close at 76,922.64 after rising as much as…

Read More
Twin Town India: Inside India's ‘twin town’ where twin births far exceed the national average

Twin Town India: Inside India’s ‘twin town’ where twin births far exceed the national average

Kerala’s mysterious ‘Twin Town,’ Kodhini, baffles scientists with an exceptionally high birth rate of twins, far exceeding national and global averages. This phenomenon, with an estimated 35 twins per 1,000 births, has led to unique local beliefs and a vibrant annual festival celebrating this extraordinary occurrence. India is the homeland of diversity and varied phenomena…

Read More
Why is stock market down today? Nifty50 goes below 23,800; BSE Sensex crashes over 1,100 points - top reasons for fall

Why is stock market down today? Nifty50 goes below 23,800; BSE Sensex crashes over 1,100 points – top reasons for fall

Stock market crash today (AI image) Stock market crash today: Indian equity benchmarks, Nifty50 and BSE Sensex, plunged in morning trade on Thursday as global cues turned negative due to a host of factors. While Nifty50 went below 23,800, BSE Sensex plunged around 1,200 points. At 11:18 AM, Nifty50 was trading at 23,810.30, down 367…

Read More
US FDA nod for 1st pill to replace jabs to fight high cholesterol

Cholesterol-Lowering Pill: US FDA nod for 1st pill to replace jabs to fight high cholesterol | India News

NEW DELHI: Patients with difficult-to-control high cholesterol could soon have an oral alternative to cholesterol-lowering injections after US Food and Drug Administration approved the world’s first oral PCSK9 inhibitor, a class of medicines that dramatically lowers “bad” cholesterol.The tablet, Lipfendra, has been approved for adults with high cholesterol, including those with an inherited condition called…

Read More